Table 1 The baseline clinical features of patients in the HT group and non-HT group
Characteristics | HT (n = 69) | Non-HT(n = 759) | P value |
|---|---|---|---|
Age (year) (median, IQR) | 70 (62–82) | 67 (59–77) | 0.022 |
Male, n (%)/female, n (%) | 46 (66.7)/23 (33.3) | 501 (66.0)/258(34.0) | 0.912 |
rt-PA, n (%)/urokinase, n (%) | 57 (82.6)/12 (17.4) | 608 (80.1)/151 (19.9) | 0.617 |
Hypertension, n (%) | 49 (71.0) | 569 (75.0) | 0.470 |
Diabetes mellitus, n (%) | 36 (52.2) | 302 (39.8) | 0.045 |
Atrial fibrillation, n (%) | 29 (42.0) | 146 (19.2) | 0.000 |
Hypercholesterolemia, n (%) | 18 (26.1) | 139 (18.3) | 0.115 |
Currently smoking, n (%) | 26 (37.7) | 374 (49.3) | 0.065 |
Previous stroke, n (%) | 46 (66.7) | 487 (64.2) | 0.678 |
Antiplatelets/Anticoagulation, n (%) | 21 (30.4) | 167 (22.0) | 0.109 |
Glucose level (mmol/L) (median, IQR) | 7.5 (5.9–9.5) | 6.4 (5.3–8.4) | 0.015 |
Systolic BP (mmHg) (median, IQR) | 150 (130–169) | 157 (140–170) | 0.138 |
NIHSS score on admission(median, IQR) | 12 (6–18) | 4 (2–8) | 0.000 |
OTT (min) (median, IQR) | 120 (60–188) | 120 (60–180) | 0.640 |
PLT count (109/L) (median, IQR) | 199 (158–247) | 206 (170–245) | 0.397 |
Body temperature (°C) (median, IQR) | 36.5 (36.5–36.6) | 36.5 (36.4–36.5) | 0.406 |